Omnicell Cash Flow from Investing Activities 2010-2024 | OMCL

Omnicell cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Omnicell Annual Cash Flow Investing
(Millions of US $)
2023 $-55
2022 $-59
2021 $-412
2020 $-280
2019 $-62
2018 $-54
2017 $-35
2016 $-341
2015 $-46
2014 $-43
2013 $-20
2012 $-169
2011 $-13
2010 $-23
2009 $-7
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.488B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.947B 19.74
Inspire Medical Systems (INSP) United States $4.693B 0.00
Hims & Hers Health (HIMS) United States $4.102B 0.00
Axonics (AXNX) United States $3.425B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.987B 0.00
Azenta (AZTA) United States $2.753B 154.79
IRhythm Technologies (IRTC) United States $2.730B 0.00
Enovis (ENOV) United States $2.727B 20.21
10x Genomics (TXG) United States $2.705B 0.00
Privia Health (PRVA) United States $2.062B 115.20
Schrodinger (SDGR) United States $1.607B 0.00
Phreesia (PHR) United States $1.296B 0.00
Standard BioTools (LAB) United States $0.936B 0.00
Fulgent Genetics (FLGT) United States $0.647B 0.00
Definitive Healthcare (DH) United States $0.645B 0.00
Clover Health Investments (CLOV) United States $0.501B 0.00
Talkspace (TALK) United States $0.480B 0.00
Health Catalyst (HCAT) United States $0.403B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.322B 0.00
Pulmonx (LUNG) United States $0.311B 0.00
Butterfly Network (BFLY) United States $0.217B 0.00
Outset Medical (OM) United States $0.206B 0.00
P3 Health Partners (PIII) United States $0.171B 0.00
TruBridge (TBRG) United States $0.146B 7.87
American Well (AMWL) United States $0.128B 0.00
111 (YI) China $0.109B 0.00
MSP Recovery (LIFW) United States $0.102B 0.00
SHL Telemedicine (SHLT) Israel $0.080B 0.00
HeartBeam (BEAT) United States $0.077B 0.00
EUDA Health Holdings (EUDA) Singapore $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.057B 0.00
Augmedix (AUGX) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.046B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Movano (MOVE) United States $0.040B 0.00
Akili (AKLI) United States $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Cue Health (HLTH) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00